La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MedCap Gestione

Gestione criteri di controllo 3/4

MedCap's Il CEO è Anders Dahlberg, nominato in Nov2020, e ha un mandato di 3.75 anni. la retribuzione annua totale è SEK 6.57M, composta da 45.3% di stipendio e 54.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.13% delle azioni della società, per un valore di SEK 10.08M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.8 anni e 2.3 anni.

Informazioni chiave

Anders Dahlberg

Amministratore delegato

SEK 6.6m

Compenso totale

Percentuale dello stipendio del CEO	45.3%
Mandato del CEO	3.8yrs
Proprietà del CEO	0.1%
Durata media del management	3.8yrs
Durata media del Consiglio di amministrazione	2.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Jun 06

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

May 21

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

May 04

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Anders Dahlberg rispetto agli utili di MedCap?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	SEK 214m
Mar 31 2024	n/a	n/a	SEK 203m
Dec 31 2023	SEK 7m	SEK 3m	SEK 172m
Sep 30 2023	n/a	n/a	SEK 150m
Jun 30 2023	n/a	n/a	SEK 149m
Mar 31 2023	n/a	n/a	SEK 123m
Dec 31 2022	SEK 7m	SEK 3m	SEK 118m
Sep 30 2022	n/a	n/a	SEK 118m
Jun 30 2022	n/a	n/a	SEK 107m
Mar 31 2022	n/a	n/a	SEK 102m
Dec 31 2021	SEK 6m	SEK 3m	SEK 97m

Compensazione vs Mercato: La retribuzione totale di Anders ($USD 636.60K ) è circa la media per le aziende di dimensioni simili nel mercato Swedish ($USD 765.82K ).

Compensazione vs guadagni: La retribuzione di Anders è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Anders Dahlberg (48 yo)

3.8yrs

Mandato

SEK 6,567,000

Compensazione

Mr. Anders Dahlberg serves as the Chief Executive Officer at MedCap AB, since November 1, 2020. Previously he served as Partner of Applied Value AB till August 2017, where he also had been a Chairman. Mr....

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Anders Dahlberg	Chief Executive Officer	3.8yrs	SEK 6.57m	0.14% SEK 10.1m
Kristina Ekblad	Chief Financial Officer	4.3yrs	Nessun dato	Nessun dato
Lars Ångman	Investment Manager	3.8yrs	Nessun dato	0.034% SEK 2.5m

3.8yrs

Durata media

Gestione esperta: Il team dirigenziale di MCAP è considerato esperto (durata media dell'incarico 3.8 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Karl Tobieson	Chairman	2.8yrs	SEK 425.00k	1.23% SEK 91.6m
Torgny Svensson	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Lena Söderström	Independent Director	2.3yrs	SEK 175.00k	Nessun dato
Karl-Olov Fagerström	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Staffan Nilsson	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Gunnar Kratz	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Holland Cheng	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Otto Ankarcrona	Independent Director	1.7yrs	SEK 175.00k	Nessun dato
David Jern	Independent Director	2.8yrs	SEK 175.00k	Nessun dato
Malin Enarson	Independent Director	1.7yrs	SEK 175.00k	Nessun dato
Anna Torner	Independent Director	2.3yrs	SEK 175.00k	Nessun dato

2.3yrs

Durata media

53yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di MCAP non è considerato esperto (durata media del mandato 2.3 anni), il che suggerisce un nuovo consiglio.

MedCap Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Chief Executive Officer recently bought kr265k worth of stock

MedCap AB (publ), Annual General Meeting, May 06, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new directors

Recent updates

Chief Executive Officer recently bought kr265k worth of stock

Second quarter 2024 earnings released: EPS: kr3.84 (vs kr3.16 in 2Q 2023)

MedCap AB (publ) to Report Q2, 2025 Results on Jul 23, 2025

Now 17% undervalued

Now 21% undervalued

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

Now 21% undervalued

MedCap AB (publ) to Report Q1, 2025 Results on Apr 29, 2025

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

First quarter 2024 earnings released: EPS: kr3.78 (vs kr1.68 in 1Q 2023)

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)

New 90-day low: kr193

MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

An unknown buyer acquired 10.1% stake in MedCap AB (publ) (OM:MCAP) from Bure Equity AB (publ) (OM:BURE).

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Market bids up stock over the past week

New 90-day high: kr233

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?